NCT02586948View on ClinicalTrials.gov

Physiological Study of Minimally Invasive ECCO2R in Exacerbations of COPD Requiring Invasive Mechanical Ventilation

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

January 14, 2018

Study Completion Date

February 12, 2018

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DEVICE

extracorporeal CO2 removal (Hemolung device)

ECCO2R in severe exacerbation of COPD patients, requiring invasive mechanical ventilation with persistent respiratory acidosis and dynamic hyperinflation

Trial Locations (3)

49933

CHU d'Angers, Angers

75015

Hopital Europeen Georges Pompidou, Paris

94275

Hopital de Bicetre, Hopitaux universitaires Paris Sud, Le Kremlin-Bicêtre

Sponsors

Collaborators (1)

Alung Technologies
All Listed Sponsors
collaborator

Alung Technologies

INDUSTRY

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02586948 - Physiological Study of Minimally Invasive ECCO2R in Exacerbations of COPD Requiring Invasive Mechanical Ventilation | Biotech Hunter | Biotech Hunter